PetVivo Holdings logo

PetVivo HoldingsNASDAQ: PETV

Profile

Sector:

Healthcare

Country:

United States

IPO:

08 September 2014

Next earnings report:

12 February 2025

Last dividends:

N/A

Next dividends:

N/A
$9.82 M
-77%vs. 3y high
18%vs. sector
-vs. 3y high
-vs. sector
-70%vs. 3y high
97%vs. sector
-99%vs. 3y high
79%vs. sector

Price

regular market | Thu, 21 Nov 2024 14:30:00 GMT
$0.47$0.00(0.00%)

Dividend

No data over the past 3 years
$200.70 K-$2.18 M

Analysts recommendations

Institutional Ownership

PETV Latest News

PetVivo Holdings, Inc. (PETV) Q2 2025 Earnings Call Transcript
seekingalpha.com14 November 2024 Sentiment: NEUTRAL

PetVivo Holdings, Inc. (OTCPK:PETV) Q2 2025 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer and General Counsel John Lai - Chief Executive Officer Garry Lowenthal - Chief Financial Officer Conference Call Participants John Dolan Good afternoon, everyone. Thank you for joining us today to discuss PetVivo's Results for its Fiscal Second Quarter ended September 30, 2024.

PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian
globenewswire.com09 September 2024 Sentiment: POSITIVE

Expert Capablites of Senior Vet-Tech to Help Drive Greater Adoption of Spryng as Breakthrough Treatment of Osteoarthritis for Companiaon Animals

Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS Technologies Inc.; Biolase, Inc.; Global Gas Corporation; Corner Growth Acquisition Corp.; Lucy Scientific Discovery Inc.; Chicken Soup for the Soul Entertainment, Inc.; Ideanomics, Inc.; NexImmune, Inc.; Shapeways Holdings, Inc.; QIWI plc;
globenewswire.com04 September 2024 Sentiment: NEGATIVE

ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market

Scot Cave Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
globenewswire.com03 September 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Scot Cave has accepted a position with the Company as its new Field Veterinary Business Development Manager to cover the Northwest Region of the United States.

Anthony Germinaro Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
globenewswire.com19 August 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, Aug. 19, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Anthony Germinaro has accepted a position with the Company as its new Field Veterinary Business Development Manager for the for the Southwest Region of the United States.

PetVivo Reports Reports Fiscal Q1 2025 Results
globenewswire.com14 August 2024 Sentiment: POSITIVE

Company Reieterates Gudience of 50% to 100% Revenue Growth in Fiscal 2025 MINNEAPOLIS, MN, US, Aug. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal first quarter ended June 30, 2024. All comparisons are to the same year-ago period unless otherwise noted.

Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
globenewswire.com12 August 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, Aug. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Eric Samples has accepted a position with the Company as its new Field Veterinary Business Development Manager to cover Ohio, Pennsylvania, and the Baltimore/DC area of the United States.

PetVivo Sets Fiscal First Quarter 2025 Conference Call for Wednesday, August 14 at 5:00 p.m. ET
globenewswire.com08 August 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, Aug. 08, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on Wednesday, August 14, 2024 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2024. The financial results will be issued in a press release prior to the call.

PetVivo Reports Reports Fiscal 2024 Results
globenewswire.com28 June 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call at 5:00 p.m. Eastern time today to discuss the results (see dial-in information below).

PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
globenewswire.com25 June 2024 Sentiment: POSITIVE

MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on Friday, June 28, 2024 at 5:00 p.m. Eastern time to discuss results for the fiscal fourth quarter and year ended March 31, 2024. The financial results will be issued in a press release prior to the call.

What type of business is PetVivo Holdings?

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

What sector is PetVivo Holdings in?

PetVivo Holdings is in the Healthcare sector

What industry is PetVivo Holdings in?

PetVivo Holdings is in the Medical Devices industry

What country is PetVivo Holdings from?

PetVivo Holdings is headquartered in United States

When did PetVivo Holdings go public?

PetVivo Holdings initial public offering (IPO) was on 08 September 2014

What is PetVivo Holdings website?

https://www.petvivo.com

Is PetVivo Holdings in the S&P 500?

No, PetVivo Holdings is not included in the S&P 500 index

Is PetVivo Holdings in the NASDAQ 100?

No, PetVivo Holdings is not included in the NASDAQ 100 index

Is PetVivo Holdings in the Dow Jones?

No, PetVivo Holdings is not included in the Dow Jones index

When was PetVivo Holdings the previous earnings report?

No data

When does PetVivo Holdings earnings report?

The next expected earnings date for PetVivo Holdings is 12 February 2025